PAPP-A


Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to PAPP-A: nuchal translucency
AcronymDefinition
PAPP-APregnancy-Associated Plasma Protein A
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Her first trimester combined screening included NT=I.8 mm (CRL =58, 1.55 MoM) and remarkable reduced PAPP-A and free BHCG (0.06 MoM and 0.13 MoM, respectively).
The Kruskal-Wallis test was used for the comparison of PAPP-A levels in OSAS patients categorized into 3 groups according to their AHI levels.
published the first report of an association between first trimester PAPP-A and PAS [69], demonstrating that that first trimester PAPP-A levels were significantly increased in PAS cases compared to nonadherent placenta previa (Table 1).
For the purposes of this review, it is key to note that both STC2, PAPP-A2, and its related gene PAPP-A were identified as being within genome-wide significant loci.
Previously, first-trimester screening test parameters including nuchal translucency, serum f[beta]-hCG, PAPP-A and ductus venosus were investigated for their associations with adverse perinatal outcomes (1,2,4,5,11).
RESULT AND ANALYSIS: After measuring the CRL, free [beta]hcg and PAPP-A values, they were converted to MoM values by computer software package (Wallac Life Cycle with Ellipse Screening Engine).
Demographic information screening test results and obstetric and perinatal outcomes were abstracted from the hospital medical recordsThe criteria adopted for diagnosis of pre- eclampsia was systolic arterial blood pressure =140 mmHg and/or diastolic arterial blood pressure =90 mmHg on two occasions separated by 6 h with=300 mg/24 h proteinuria.1011 Serum concentrations of AY-hCG and PAPP-A were analyzed by specific immunoassay at the time of serum sampling as part of the routine screening for fetal Down's Syndrome and all results were expressed as multiple of the median (MoM) of the expected normal median for a pregnancy of the same gestational age.Ultrasonographic assessment was carried out by two experienced obstetric sonographers at gestational weeks 11+0 to 13+6.
In both the EO-PE and LO-PE groups PAPP-A were lower compared to unaffected pregnancies; there were no significant differences in free [beta]-hCG, CRL, and NT.
In this study, we set out to evaluate the PAPP-A and free-hCG[beta] AutoDELFIA DBS dual assay and compare it with the corresponding AutoDELFIA serum-based assays.
Area under curve (AUC) and 95% CI of hs CRP 0.817 (0.736-.881) was significantly higher than that of MPO 0.685 (0.594-0.766) (p=0.018) and PAPP-A 0.565 (0.472-0.655) (p less than0.001) for the diagnosis of SCAD.
Although samples are tested in house before release, using PAPP-A enzyme-linked immunosorbent assay (Diagnostic Systems Laboratory, Webster, Texas), VICTOR platforms (PerkinElmer, Waltham, Massachusetts), hCG and inhibin-A (UniCel DxI, Beckman Coulter, Brea, California), and the free [beta]-hCG subunit (VICTOR), neither the nominal targeted concentration nor the prefill result is used in determining performance.
A new panel of prenatal supervision kits is available: the PLGF ELISA (new marker for preelampsia), and PAPP-A ELISA, as well as the new DRG PKU Neonatal Screening Assay Kit.